As LDL-mediated increase in SERPINE2 expression was reverted by using an anti-Human LDLR receptor antibody, we then tested the hypothesis that this antibody could prevent the increased intravasation capacity of breast cancer cells mediated by the high cholesterol diet in vivo. Here, SERPINE2 is linked to breast cancer.